The Surgical Management of Medullary Thyroid Cancer

被引：16

作者：

Dackiw, Alan P. B. ^{[1
]}

机构：

[1] Johns Hopkins Univ, Sch Med, Div Endocrine & Oncol Surg, Dept Surg,Sect Endocrine Surg,Johns Hopkins Hosp, Baltimore, MD 21287 USA

来源：

OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA | 2010年 / 43卷 / 02期

关键词：

Medullary thyroid cancer; Treatment guidelines; Evidence-based treatment; Surgical techniques; DNA testing; Prognosis; Thyroidectomy; ENDOCRINE NEOPLASIA TYPE-2A; PROGNOSTIC-FACTORS; CARCINOMA; REOPERATION; RECURRENT; METASTASES; PERSISTENT; GUIDELINES; STRATEGY; STAGE;

D O I：

10.1016/j.otc.2010.01.006

中图分类号：

R76 [耳鼻咽喉科学];

学科分类号：

100213 ;

摘要：

Medullary thyroid cancer (MTC), accounts for approximately 5% to 10% of all thyroid cancers. Significant advances in the understanding of the biology and clinical outcomes of MTC have been made over the last decade, culminating most recently in the publication of treatment guidelines by the American Thyroid Association that follow an evidence-based approach that is summarized in this presentation. Prognosis, genetic testing, surgical technique, and re-operation are also discussed.

引用

页码：365 / +

页数：11

共 50 条

[41] Influence of lymph node metastases on survival in pediatric medullary thyroid cancer
Raval, Mehul V.
Sturgeon, Cord
Bentrem, David J.
Elaraj, Dina M.
Stewart, Andrew K.
Winchester, David J.
Ko, Clifford Y.
Reynolds, Marleta
JOURNAL OF PEDIATRIC SURGERY, 2010, 45 (10) : 1947 - 1954
[42] The surgical management of thyroid cancer
Abdul-Jabar, HB
Lynn, J
NUCLEAR MEDICINE COMMUNICATIONS, 2004, 25 (09) : 869 - 872
[43] Management of treatment-related toxicities in advanced medullary thyroid cancer
Brose, Marcia S.
Bible, Keith C.
Chow, Laura Q. M.
Gilbert, Jill
Grande, Carolyn
Worden, Francis
Haddad, Robert
CANCER TREATMENT REVIEWS, 2018, 66 : 64 - 73
[44] Medullary Thyroid Cancer Overview and case study of a rare cancer
Jakobs, Lynn
CLINICAL JOURNAL OF ONCOLOGY NURSING, 2018, 22 (02) : E37 - E43
[45] Charting a course through the CEAs: diagnosis and management of medullary thyroid cancer
Rowe, Christopher W.
Bendinelli, Cino
McGrath, Shaun
CLINICAL ENDOCRINOLOGY, 2016, 85 (03) : 340 - 343
[46] Management of treatment-related toxicities in advanced medullary thyroid cancer
Tsang, Venessa H. M.
CURRENT OPINION IN ONCOLOGY, 2019, 31 (03) : 236 - 242
[47] Management of the lateral neck compartment in patients with sporadic medullary thyroid cancer
Pena, Israel
Clayman, Gary L.
Grubbs, Elizabeth G.
Bergeron, Jeffrey M., Jr.
Waguespack, Steven G.
Cabanillas, Maria E.
Dadu, Ramona
Hu, Mimi I.
Fellman, Bryan M.
Li, Yisheng
Gross, Neil D.
Lai, Stephen Y.
Sturgis, Erich M.
Zafereo, Mark E.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2018, 40 (01): : 79 - 85
[48] Routine preoperative 111In-octreotide scintigraphy in patients with medullary thyroid cancer
Dahlberg, Jakob
Bumming, Per
Gjertsson, Peter
Jansson, Svante
LANGENBECKS ARCHIVES OF SURGERY, 2013, 398 (06) : 875 - 880
[49] Medullary thyroid cancer. Review of 28 patients
Pulgar B, Dahiana
Jans B, Jaime
Petric G, Militza
Leon R, Augusto
Camus A, Mauricio
Goni E, Ignacio
Dominguez C, Francisco
Droppelmann M, Nicolas
Claure S, Raul
Gonzalez D, Hernan
REVISTA MEDICA DE CHILE, 2013, 141 (11) : 1395 - 1401
[50] Calcitonin determination for early diagnosis of medullary thyroid cancer
Karges, W.
CHIRURG, 2010, 81 (07): : 620 - +

← 1 2 3 4 5 →